1 |
Lennon R, Watson L, Webb NJA. Nephrotic syndrome in children[J]. Paediatr and Child Health. 2010, 20(1): 36-42.
|
2 |
Sinha A, Bagga A. Nephrotic syndrome [J]. Indian J Pediatr,2012, 79(8): 1045-1055.
|
3 |
Ernould S, Godron A, Nelson JR, et al. Idiopathic nephrotic syndrome in children: Incidence, clinical presentation, and outcome in the county of Gironde, France [J]. Arch Pediatr, 2011,18(5): 522-528.
|
4 |
Esfahani ST, Madani A, Asgharian F, et al. Clinical course and outcome of children with steroid-sensitive nephrotic syndrome [J].Pediatr Nephrol, 2011, 26(7): 1089-1093.
|
5 |
Greenbaum LA, Benndorf R, Smoyer WE. Childhood nephrotic syndrome--current and future therapies [J]. Nat Rev Nephrol,2012, 8(8): 445-458.
|
6 |
Davin JC, Rutjes NW. Nephrotic syndrome in children: from bench to treatment [J]. Int J Nephrol, 2011, 2011: 372304.
|
7 |
van Husen M, Kemper MJ. New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome [J]. Pediatr Nephrol, 2011, 26(6): 881-892.
|
8 |
Mehls O, Hoyer PF. Dosing of glucocorticosteroids in nephrotic syndrome [J]. Pediatr Nephrol, 2011, 26(12): 2095-2098.
|
9 |
Roberti I, Vyas S. Long-term outcome of children with steroidresistant nephrotic syndrome treated with tacrolimus [J]. Pediatr Nephrol, 2010, 25(6): 1117-1124.
|
10 |
中华医学会儿科分会肾脏病学组. 激素敏感、复发或依赖肾病综合征诊治循证指南 [J]. 中华儿科杂志, 2009,47(3): 167-169.
|
11 |
中华医学会儿科分会肾脏病学组.儿童常见肾脏疾病诊治循证指南(试行)(三):激素耐药型肾病综合征诊治指南[J]. 中华儿科杂志, 2010, (1): 72-75.
|
12 |
Lombel RM, Hodson EM, Gipson DS. Treatment of steroidresistant nephrotic syndrome in children: new guidelines from KDIGO [J]. Pediatr Nephrol, 2012, 28(3): 409-414.
|
13 |
Lombel RM, Gipson DS, Hodson EM. Treatment of steroidsensitive nephrotic syndrome: new guidelines from KDIGO [J].Pediatr Nephrol, 2012, 28(3): 415-426.
|
14 |
中华医学会儿科分会肾脏病学组. 诊断及治疗小儿肾小球疾病的临床分类. 小儿肾小球疾病的临床分类、诊断及治疗[J].中华儿科杂志, 2001, 39(12): 476-477.
|
15 |
van Husen M, Kemper MJ. New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome [J]. Pediatr Nephrol, 2011, 26(6): 881-892.
|
16 |
Hodson EM, Willis NS, Craig JC. Interventions for idiopathic steroid-resistant nephrotic syndrome in children [J/CD]. Cochrane Database Syst Rev, 2010, 10(11): 3594.
|
17 |
任献国,刘光陵,夏正坤,等. 儿童肾病综合征肾组织病理光镜和免疫荧光分型的关系[J]. 临床儿科杂志, 2012, 30(2): 147-149.
|
18 |
Guyatt GH, Oxman AD, Schunemann HJ, et al. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology [J]. J Clin Epidemiol, 2011, 64(4): 380-382.
|
19 |
Meerpohl JJ, Langer G, Perleth M, et al. GRADE guidelines: 3.Rating the quality of evidence (confidence in the estimates of effect) [J]. Z Evid Fortbild Qual Gesundhwes, 2012, 106(6): 449-456.
|
20 |
Hodson EM, Willis NS, Craig JC. Corticosteroid therapy for nephrotic syndrome in children [J/CD]. Cochrane Database Syst Rev, 2007, (4): 1533.
|
21 |
Mattoo TK, Mahmoud MA. Increased maintenance corticosteroids during upper respiratory infection decrease the risk of relapse in nephrotic syndrome [J]. Nephron, 2000, 85(4): 343-345.
|
22 |
Abeyagunawardena AS, Trompeter RS. Increasing the dose of prednisolone during viral infections reduces the risk of relapse in nephrotic syndrome: a randomised controlled trial [J]. Arch Dis Child, 2008,93(3): 226-228.
|
23 |
Gulati A, Sinha A, Sreenivas V, et al. Daily corticosteroids reduce infection-associated relapses in frequently relapsing nephrotic syndrome: a randomized controlled trial [J]. Clin J Am Soc Nephrol, 2011, 6(1): 63-69.
|
24 |
Elzouki A Y, Jaiswal O P. Long-term, small dose prednisone therapy in frequently relapsing nephrotic syndrome of childhood.Effect on remission, statural growth, obesity, and infection rate [J].Clin Pediatr (Phila),1988, 27(8): 387-392.
|
25 |
Srivastava R N, Vasudev A S, Bagga A, et al. Long-term, lowdose prednisolone therapy in frequently relapsing nephrotic syndrome [J]. Pediatr Nephrol,1992, 6(3): 247-250.
|
26 |
El-Husseini A, El-Basuony F, Mahmoud I, et al. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome:a single-centre experience [J]. Nephrol Dial Transplant, 2005,20(11): 2433-2438.
|
27 |
Hamed R M. Treatment of idiopathic nephrotic syndrome with cyclosporin A in children [J]. J Nephrol, 1997, 10(5): 266-270.
|
28 |
Ghiggeri G M, Catarsi P, Scolari F, et al. Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label,nonrandomized, retrospective study [J]. Clin Ther, 2004, 26(9):1411-1418.
|
29 |
Sinha M D, Macleod R, Rigby E, et al. Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus [J]. Nephrol Dial Transplant, 2006, 21(7): 1848-1854.
|
30 |
Wang W, Xia Y, Mao J, et al. Treatment of tacrolimus or cyclosporine A in children with idiopathic nephrotic syndrome[J].Pediatr Nephrol,2012,27(11):2073-2079.
|
31 |
曹琦,黄文彦,徐虹,等. 长疗程环孢素A治疗儿童激素耐药型肾病综合征的疗效和预后 [J]. 中华儿科杂志, 2008, 46(9):698-701.
|
32 |
Choudhry S, Bagga A, Hari P, et al. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial [J]. Am J Kidney Dis, 2009, 53(5): 760-769.
|
33 |
Ruf R G, Lichtenberger A, Karle S M, et al. Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome [J]. J Am Soc Nephrol, 2004,15(3): 722-732.
|
34 |
Malina M, Cinek O, Janda J, et al. Partial remission with cyclosporine A in a patient with nephrotic syndrome due to NPHS2 mutation [J]. Pediatr Nephrol, 2009, 24(10): 2051-2053.
|
35 |
Gellermann J, Stefanidis C J, Mitsioni A, et al. Successful treatment of steroid-resistant nephrotic syndrome associated with WT1 mutations [J]. Pediatr Nephrol, 2010, 25(7):1285-1289.
|
36 |
Bensman A, Niaudet P. Non-immunologic mechanisms of calcineurin inhibitors explain its antiproteinuric effects in genetic glomerulopathies [J]. Pediatr Nephrol, 2010, 25(7): 1197-1199.
|
37 |
Latta K, von Schnakenburg C, Ehrich J H. A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children [J]. Pediatr Nephrol, 2001, 16(3): 271-282.
|
38 |
孙嫱,沈颖. Meta 分析评价环磷酰胺对儿童肾病综合征的治疗作用[J]. 中华儿科杂志, 2006, 44(3): 199-201.
|
39 |
Hodson EM, Willis NS, Craig JC. Non-corticosteroid treatment for nephrotic syndrome in children [J/CD]. Cochrane Database Syst Rev, 2008, 23(1): CD002290.
|
40 |
Children I S O K. Prospective, controlled trial of cyclophosphamide therapy in children with nephrotic syndrome. Report of the International study of Kidney Disease in Children [J]. Lancet,1974, 24, 2(7878): 423-427.
|
41 |
Tarshish P, Tobin J N, Bernstein J, et al. Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. A report of the International Study of Kidney Disease in Children [J].Pediatr Nephrol, 1996, 10(5): 590-593.
|
42 |
Afzal K, Bagga A, Menon S, et al. Treatment with mycophenolate mofetil and prednisolone for steroid-dependent nephrotic syndrome [J]. Pediatr Nephrol, 2007, 22(12): 2059-2065.
|
43 |
Gellermann J, Querfeld U. Frequently relapsing nephrotic syndrome: treatment with mycophenolate mofetil [J]. Pediatr Nephrol, 2004, 19(1): 101-104.
|
44 |
Bagga A, Hari P, Moudgil A, et al. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome [J]. Am J Kidney Dis, 2003, 42(6): 1114-1120.
|
45 |
Li Z, Duan C, He J, et al. Mycophenolate mofetil therapy for children with steroid-resistant nephrotic syndrome [J]. Pediatr Nephrol, 2010, 25(5): 883-888.
|
46 |
de Mello VR, Rodrigues MT, Mastrocinque TH, et al.Mycophenolate mofetil in children with steroid/cyclophosphamideresistant nephrotic syndrome [J]. Pediatr Nephrol, 2010, 25(3):453-460.
|
47 |
Gargah TT, Lakhoua MR. Mycophenolate mofetil in treatment of childhood steroid-resistant nephrotic syndrome [J]. J Nephrol,2011, 24(2): 203-207.
|
48 |
Guigonis V, Dallocchio A, Baudouin V, et al. Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome:a multicentric series of 22 cases [J]. Pediatr Nephrol, 2008, 23(8):1269-1279.
|
49 |
Ravani P, Magnasco A, Edefonti A, et al. Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial [J]. Clin J Am Soc Nephrol, 2011, 6(6): 1308-1315.
|
50 |
Sun L, Xu H, Cao Q, et al. Efficacy of rituximab therapy in children with refractory nephrotic syndrome: A prospective observational study in Shanghai [J]. World J Pediatr, 2013. [Epub ahead of print]
|
51 |
Ito S, Kamei K, Ogura M, et al. Maintenance therapy with mycophenolate mofetil after rituximab in pediatric patients with steroid-dependent nephrotic syndrome [J]. Pediatr Nephrol, 2011,26(10): 1823-1828.
|
52 |
Magnasco A, Ravani P, Edefonti A, et al. Rituximab in children with resistant idiopathic nephrotic syndrome [J]. J Am Soc Nephrol, 2012, 23(6): 1117-1124.
|
53 |
Yoshioka K, Ohashi Y, Sakai T, et al. A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndrome [J]. Kidney Int, 2000, 58(1): 317-324.
|
54 |
Kemper MJ, Amon O, Timmermann K, et al. The treatment with levamisole of frequently recurring steroid-sensitive idiopathic nephrotic syndrome in children [J]. Dtsch Med Wochenschr,1998, 123(9): 239-243.
|
55 |
Sumegi V, Haszon I, Ivanyi B, et al. Long-term effects of levamisole treatment in childhood nephrotic syndrome [J]. Pediatr Nephrol, 2004, 19(12): 1354-1360.
|
56 |
Fu LS, Shien CY, Chi CS. Levamisole in steroid-sensitive nephrotic syndrome children with frequent relapses and/or steroid dependency: comparison of daily and every-other-day usage [J].Nephron Clin Pract, 2004, 97(4): c137-c141.
|
57 |
Madani A, Isfahani S T, Rahimzadeh N, et al. Effect of levamisole in steroid-dependent nephrotic syndrome [J]. Iran J Kidney Dis,2010, 4(4): 292-296.
|
58 |
Levamisole for corticosteroid-dependent nephrotic syndrome in childhood. British Association for Paediatric Nephrology [J].Lancet, 1991, 337(8757): 1555-1557.
|
59 |
Abeyagunawardena AS, Hindmarsh P, Trompeter RS. Adrenocortical suppression increases the risk of relapse in nephrotic syndrome [J].Arch Dis Child, 2007, 92(7): 585-588.
|
60 |
Kane KF, Emery P, Sheppard MC, et al. Assessing the hypothalamopituitary-adrenal axis in patients on long-term glucocorticoid therapy: the short synacthen versus the insulin tolerance test [J].QJM, 1995, 88(4): 263-267.
|
61 |
Arun S, Bhatnagar S, Menon S, et al. Efficacy of zinc supplements in reducing relapses in steroid-sensitive nephrotic syndrome [J].Pediatr Nephrol, 2009, 24(8): 1583-1586.
|
62 |
Prasher PK, Varma PP, Baliga KV. Efficacy of enalapril in the treatment of steroid resistant idiopathic nephrotic syndrome [J]. J Assoc Physicians India,1999, 47(2): 180-182.
|
63 |
Bagga A, Mudigoudar BD, Hari P, et al. Enalapril dosage in steroid-resistant nephrotic syndrome [J]. Pediatr Nephrol, 2004,19(1): 45-50.
|
64 |
Yi Z, Li Z, Wu X C, et al. Effect of fosinopril in children with steroid-resistant idiopathic nephrotic syndrome [J]. Pediatr Nephrol, 2006, 21(7): 967-972.
|
65 |
Hodson EM, Habashy D, Craig JC. Interventions for idiopathic steroid-resistant nephrotic syndrome in children [J/CD]. Cochrane Database Syst Rev, 2009, 19(2): CD003594.
|